Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Berlin

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
Frontiers in Oncology|September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
JCO Oncology Practice|January 24, 2024
Virtual Cancer Care Beyond the COVID-19 Pandemic: Patient and Staff Perspectives and RecommendationsNazek Abdelmutti, Melanie Powis, Alyssa Macedo, et al.
Journal of the National Cancer Institute|June 7, 2023
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancerAlejandro Berlin, Matthew Ramotar, Anna T Santiago, et al.
Frontiers in Oncology|December 5, 2022
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
World Neurosurgery|June 7, 2021
Radiation Dose Rate, Biologically Effective Dose, and Tumor Characteristics on Local Control and Toxicity After Radiosurgery for Acoustic NeuromasConrad Josef Villafuerte, David B Shultz, Normand Laperriere, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancerFabio Y Moraes, Alireza Mansouri, Archya Dasgupta, et al.
BMC Cancer|June 18, 2024
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancerXinpei Ci, Sujun Chen, Rui Zhu, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Oncology|September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
JCO Oncology Practice|January 24, 2024
Virtual Cancer Care Beyond the COVID-19 Pandemic: Patient and Staff Perspectives and RecommendationsNazek Abdelmutti, Melanie Powis, Alyssa Macedo, et al.
Journal of the National Cancer Institute|June 7, 2023
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancerAlejandro Berlin, Matthew Ramotar, Anna T Santiago, et al.
Frontiers in Oncology|December 5, 2022
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
World Neurosurgery|June 7, 2021
Radiation Dose Rate, Biologically Effective Dose, and Tumor Characteristics on Local Control and Toxicity After Radiosurgery for Acoustic NeuromasConrad Josef Villafuerte, David B Shultz, Normand Laperriere, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancerFabio Y Moraes, Alireza Mansouri, Archya Dasgupta, et al.
BMC Cancer|June 18, 2024
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancerXinpei Ci, Sujun Chen, Rui Zhu, et al.
Pageof 23